News
Sep 13, 2018
Breakfast symposium and immersive booth activities highlight capabilities of vascular robotic technology and importance of remote access to care at the TCT conference in San Diego, CA. | Read More
Diabetes Does Not Affect 30-Day Post-Revascularization Outcomes in Patients with CLTI
Aug 28, 2018
In patients with chronic limb-threatening ischemia (CLTI) and diabetes, 30-day post-revascularization outcomes are similar to those observed in CLTI patients without diabetes, according to a study in the Journal of Vascular Surgery. | Read More
Stent Graft Rotation During Advanced EVAR Increases Risk of Postoperative Complications
Jul 28, 2018
A study in the Journal of Vascular Surgery investigates the incidence of stent graft rotation during advanced EVAR. | Read More
FDA Approves Gore Cardioform Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
Apr 06, 2018
The FDA has approved an expanded indication of the Gore Cardioform Septal Occluder. | Read More
MR CLEAN Registry: Strong Link Between Stroke Outcomes, Time to Endovascular Treatment
Apr 03, 2018
The association between time to endovascular treatment and functional outcome in patients with acute ischemic stroke may be stronger than previously suggested. | Read More
FDA Approves Expanded Indication for Vascade Vascular Closure System
Apr 01, 2018
The FDA has approved an expanded indication of the Vascade Vascular Closure System, according to an announcement by Cardiva Medical. | Read More
Varicose Veins Linked With Increased Risk of DVT
Mar 07, 2018
Varicose veins are significantly associated with risk of developing deep vein thrombosis (DVT), researchers reported in JAMA. | Read More
Feb 06, 2018
The authors followed the 12 month outcomes of 101 patients at 17 centers who participated in the OPTALYSE PE study in which the patients were randomized one of four cohorts. | Read More
Thrombectomy Effective Up to 16 Hours: DEFUSE 3 Trial
Jan 31, 2018
Current recommendations say that patients are eligible for thrombectomy within 6 hours of a stroke, but newly released results from the DEFUSE 3 trial suggest that the window of opportunity may extend up to 16 hours in certain patients. | Read More
Early TEVAR May Be Appropriate in Some Patients
Jan 19, 2018
Using certain clinical and anatomic features as a guide, it may be possible to predict whether patients with medically managed type B aortic dissection (TBAD) will benefit from early TEVAR. | Read More
